Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




$1.3 Million Grant to Develop New Imaging Technique

By HospiMedica International staff writers
Posted on 11 Jun 2009
An American company has just received a U.S grant to develop a new imaging technology, called differential phase contrast imaging, which will utilize the unique X-ray beam produced by the Compact Light Source (CLS) synchrotron. More...


The CLS, developed by Lyncean Technologies, Inc. (Palo Alto, CA, USA), is a miniature synchrotron to produce high-intensity, tunable, near-monochromatic X-ray beams. The CLS was specifically designed to bring state-of-the-art protein structure determination to the university or industrial laboratory--but it has also promised a broad impact across the spectrum of X-ray science.

Lyncean Technologies has just received a phase I Small Business Innovation Research (SBIR) grant of nearly US$1.3 million from the U.S. National Center for Research Resources (NCRR). The grant will allow Lyncean to continue its ongoing development of the Compact Light Source and its applications to new methods of imaging.

The CLS effort was funded by the U.S. National Institute of General Medical Sciences (NIGMS; Bethesda, MD, USA) SBIR program as an advanced technology related to the NIGMS Protein Structure Initiative (PSI). The CLS technology is based on an electron beam stored in a miniature storage ring colliding repeatedly with an opposing infrared light pulse stored in a high-finesse cavity. Each collision produces X-rays through inverse Compton scattering. The entire X-ray source fits in a 3 x 7.6 m room similar in size to those used for magnetic resonance imaging (MRI) in medical clinics.

The first scientific publication using the CLS X-ray beam employed a technique called differential phase contrast imaging (DPCI) developed by Prof. Franz Pfeiffer (now at TU Munich, Germany) and collaborators at the Paul Scherrer Institute (Villigen PSI, Switzerland). DPCI uses a pair of micron-scale gratings to create three images: an absorption image enhanced by the X-ray beam quality, a second image sensitive to the phase of the X-ray wave front, and a third image sensitive to the local scattering power. This technique has been primarily developed at the X-ray beam lines in large synchrotrons, and it relies on a small point-like, monochromatic X-ray source to achieve the coherence necessary for the fringes. The DPCI technique has already demonstrated superior visualization of soft tissue in many publications. The Compact Light Source has an X-ray beam that is a perfect match for the technique.

This new grant will permit the development of an X-ray imaging system called the clinical high-resolution imaging system (CHRIS), which takes advantage of the unique properties of the CLS X-ray beam. The CLS X-ray beam emerges from a tiny spot (about 100 microns) and diverges in a cone to illuminate first the sample and then the gratings, which are specifically designed to produce X-ray fringes. The diverging monochromatic beam already produces very high-resolution images and tomography, due to the point-like source and monochromatic X-ray energy. Moreover, the gratings permit the creation of the two additional images, using the new phase and scattering contrast mechanisms, which are not possible in conventional radiographs. The combination of these three images can distinguish subtle variations in soft tissue at an extremely fine scale.

When complete, the CHRIS development aims towards a device that will enable the development of clinical applications of this new imaging method towards cancer detection, mammography, osteoarthritis, small animal imaging and other clinical radiologic applications that require the detection of fine structure within soft tissue.

Related Links:

Lyncean Technologies
National Institute of General Medical Sciences



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: Lead study author Ramy Ghanim (left) and co-author Joy Jackson test an small implantable device alongside Assistant Professor Alex Abramson. In a new Science paper, they describe a networking system that connects therapeutic implants and wearable devices by using the body’s natural conductivity to send tiny signals. (Photo courtest of Georgia Tech)

Bioelectronic Network Enables Devices to Communicate Through Body Tissue and Coordinate Therapy

Wearable sensors and implanted therapeutic devices can be difficult to coordinate when signals must pass through the body. Conventional wireless signals do not travel well through tissue, while the antennas... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.